In English | En español
Questions About Cancer? 1-800-4-CANCER

Featured Clinical Trials

Highlighted NCI-Supported Cancer Studies < Back to Main

Page Options

  • Print This Page
  • Email This Document

Search Featured Trials

Liver Cancer - Featured Clinical Trials

The following list shows Featured Clinical Trials for a specific type of cancer. You may also want to view:

Targeted Therapy for Liver or Biliary Tract Cancer
(Posted: 02/21/2006, Updated: 06/04/2007) - In this clinical trial, researchers are testing the ability of a new drug called lapatinib to delay tumor growth and possibly improve the survival of patients with inoperable hepatocellular or biliary tract cancer. Lapatinib works by disrupting chemical signals that stimulate the growth and spread of cancer cells.

New Strategy for Treatment-Resistant Solid Tumors in Children
(Posted: 06/13/2006) - This clinical trial will assess the safety of of a drug called talabostat in combination with chemotherapy in pediatric patients with cancer who have not responded to or gotten worse after other treatments.

Targeted Combination Therapy for Advanced Solid Tumors
(Posted: 07/19/2005) - In this study, researchers are assessing the safety and combined effectiveness of bevacizumab and a second drug called sorafenib. Both bevacizumab and sorafenib inhibit the formation of blood vessels to tumors and may act synergistically when combined.

< Previous  1 2